Motivating Officers and Employees Through Stock Options
First written in FY2016. 14 of 16 entries say "Advanced", first in FY2020. Latest entry: 2026-07-01.
106 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「At its meeting held on 22 May 2026, the Company's Board of Directors resolved to seek approval for the free issuance of stock acquisition rights as stock options to the Company's directors and external collaborators pursuant to Articles 236, 238 and 239 of the Companies Act, and for the delegation to the Board of Directors of the authority to determine the offering terms. The issuance of the stock options was approved at the Company's 26th Annual General Meeting of Shareholders held on 23 June 2026.」
Following the Series 18 Stock Acquisition Rights, the issuance of new stock options covering up to 30,000 shares to directors and external collaborators was approved, further formalising their continued implementation. - FY2026-H1AdvancedAnnual report
「Series 18 Stock Acquisition Rights (issued on 1 July 2025 pursuant to a resolution of the Board of Directors dated 20 June 2025)」
The Series 18 Stock Acquisition Rights were issued on 1 July 2025. They were granted to 9 employees of the Company and 1 external collaborator, covered 30,000 shares, and may be exercised from 2 July 2027 to 31 May 2035. - FY2025AdvancedAnnual report
「30,000 common shares of the company」
As a subsequent event, the company disclosed a resolution to issue stock acquisition rights covering 30,000 shares, scheduled to be allotted on 1 July 2025 to employees and outside collaborators, further formalising the ongoing implementation of stock options. - FY2025-H1AdvancedAnnual report
「17th Series of Stock Acquisition Rights (issued on 1 July 2024 pursuant to a resolution of the Board of Directors dated 21 June 2024)」
The stock acquisition rights covering up to 30,000 shares that were approved and resolved in the previous fiscal year were issued as the 17th Series of Stock Acquisition Rights on 1 July 2024. The recipients were 1 director, 1 corporate auditor and 4 employees, and the exercise period runs from 2 July 2026 to 31 May 2034. - FY2024AdvancedAnnual report
「30,000 common shares of the company」
As a subsequent event, the company approved and resolved the issuance of stock acquisition rights covering 30,000 shares, scheduled to be allotted on 1 July 2024 to directors, corporate auditors and employees. - FY2024-Q2AdvancedAnnual report
「16th Series of Stock Acquisition Rights (issued on 1 July 2023 pursuant to a resolution of the Board of Directors dated 21 June 2023)」
The 16th Series of Stock Acquisition Rights was issued on 1 July 2023. The recipients were 1 director and 2 employees; the number of underlying shares was 15,000, and the exercise period runs from 2 July 2025 to 31 May 2033. - FY2023-Q2AdvancedAnnual report
「15th Series of Stock Acquisition Rights (issued on 1 July 2022 pursuant to a resolution of the Board of Directors dated 21 June 2022)」
The disclosure states that the 15th Series of Stock Acquisition Rights, for which the policy and maximum number had been disclosed in the previous filing, was issued on 1 July 2022. The recipients were 1 director, 2 employees and 1 outside collaborator; the number of underlying shares was 11,000, and the exercise period runs from 2 July 2024 to 31 May 2032. - FY2022AdvancedAnnual report
「The maximum number of shares underlying the stock acquisition rights is set at 11,000 of the company's common shares.」
Pursuant to resolutions of the Board of Directors dated 20 May 2022 and the General Meeting of Shareholders dated 21 June 2022, the policy for issuing new stock options covering up to 11,000 shares to directors, employees and outside collaborators was formalised. - FY2021-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows: 14th Series of Stock Acquisition Rights (issued on 1 July 2020 pursuant to a resolution of the Board of Directors dated 22 June 2020).」
The disclosure states that the 14th Series of Stock Acquisition Rights, for which approval had been disclosed in the previous filing, was issued on 1 July 2020. The recipients were 17 employees of the company; the number of underlying shares was 107,000, and the exercise period runs from 2 July 2022 to 31 May 2030. - FY2020AdvancedAnnual report
「The maximum number of shares underlying the stock acquisition rights is set at 107,000 of the company's common shares.」
The disclosure covers approval for the issuance of the 14th series of stock acquisition rights, covering up to 107,000 common shares, intended to motivate officers and employees. - FY2018RestatedAnnual report
「The stock option plan was introduced to align the interests of the company with those of its individual officers and employees, enhance motivation in their duties through the sharing of the vision and achievement of targets, and increase corporate auditors' motivation to enhance corporate value through proper and rigorous audits. Although the company will continue to consider the plan carefully as part of its capital policy, it basically intends to implement it on an ongoing basis.」
The company has reaffirmed its policy of continuing stock options to motivate officers, employees and corporate auditors and enhance corporate value. - FY2016First statedAnnual report
「The stock option plan was introduced to align the interests of the company with those of its individual officers and employees, enhance motivation in their duties through the sharing of the vision and achievement of targets, and increase corporate auditors' motivation to enhance corporate value through proper and rigorous audits. Although the company will continue to consider the plan carefully as part of its capital policy, it basically intends to implement it on an ongoing basis.」
The company stated its intention to continue implementing stock options to motivate officers, employees and corporate auditors and enhance corporate value.